Stock Report

All about this stock under one free report Last Updated: 30-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Acutaas Chemicals Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ACUTAAS | BSE: 543349

₹3,279.40

up-down-arrow ₹-24.70 (-0.75%)

As on 30-Sep-2026 15:31IST

Market cap

info icon

₹26,957 Cr

Revenue (TTM)

info icon

₹1,462 Cr

P/E Ratio

info icon

69.8

P/B Ratio

info icon

15.6

Div. Yield

info icon

0.1 %

Edit peer-selector-edit
Acutaas Chemicals Wockhardt Piramal Pharma Rubicon Research Granules India
Market cap (₹ Cr)
 26,957 34,920 27,506 26,661 23,245
Revenue (₹ Cr)
 1,462 3,564 9,205 1,936 5,632
Net Profit (₹ Cr)
 387.35 414.00 -371.81 288.22 662.35
Net Margin (%)
 26.01 11.23 -3.93 14.79 11.75
RoE (%)
 25.18 8.38 -3.85 29.77 14.34
Price to Earnings
 69.80 85.38 -- 92.51 35.09
Price-To-Book
 15.62 6.94 3.44 19.86 4.74

Income Statement (₹ Cr)

Acutaas Chemicals Wockhardt Piramal Pharma Rubicon Research Granules India
Operating Revenue arrow
1,461.80 3,564.00 9,205.28 1,935.80 5,632.31
Total Income arrow
1,489.25 3,686.00 9,449.59 1,948.58 5,638.56
Total Expenditure arrow
919.25 2,792.00 8,195.15 1,485.56 4,354.97
EBITDA arrow
542.56 772.00 1,010.13 450.24 1,277.34
Depreciation arrow
37.68 226.00 857.51 50.83 306.94
EBIT arrow
504.88 546.00 152.62 399.41 970.39
Interest arrow
3.77 217.00 342.73 40.84 111.70
Other Income arrow
27.45 122.00 244.31 12.78 6.25
Exceptional Items arrow
0.00 12.00 -216.88 0.00 15.92
Profit before Tax arrow
528.56 463.00 -162.68 371.35 880.86
Provision for Tax arrow
141.21 49.00 209.13 83.14 218.51
Profit after Tax arrow
387.35 414.00 -371.81 288.22 662.35

Liabilities (₹ Cr)

Acutaas Chemicals Wockhardt Piramal Pharma Rubicon Research Granules India
Shareholder's Funds arrow
1,653.56 4,940.00 8,162.62 1,288.82 5,085.00
Minority Interest arrow
-1.13 -5.00 0.00 0.00 0.00
Non-Current Liabilities arrow
42.40 1,712.00 5,044.14 202.03 542.92
Current Liabilities arrow
230.82 1,622.00 4,758.28 835.87 2,092.03
Total Liabilities arrow
1,983.96 8,578.00 17,723.32 2,326.71 7,682.91

Assets (₹ Cr)

Acutaas Chemicals Wockhardt Piramal Pharma Rubicon Research Granules India
Non-Current Assets arrow
1,026.85 5,343.00 10,211.52 519.60 3,533.26
Current Assets arrow
881.27 2,606.00 7,191.66 1,681.81 3,767.65
Total Assets arrow
1,983.96 8,578.00 17,723.32 2,326.71 7,682.91
Total Debt* arrow
26.49 2,125.00 5,495.48 259.37 1,338.13
Net Current Assets arrow
650.46 984.00 2,433.38 845.94 1,675.62
Contingent Liabilities arrow
17.25 768.26 95.72 19.09 0.93

Cashflow (₹ Cr)

Acutaas Chemicals Wockhardt Piramal Pharma Rubicon Research Granules India
Cash From Operating Activities arrow
292.17 390.00 1,652.60 205.05 793.25
Cash Flow from Investing Activities arrow
-265.94 -241.00 -826.03 -409.72 -773.21
Cash from Financing Activities arrow
4.10 -54.00 -38.98 283.07 379.29
Net Cash Inflow / Outflow arrow
30.33 95.00 787.59 78.39 399.33

Ratios

Profitability Ratios

 Acutaas Chemicals Wockhardt Piramal Pharma Rubicon Research Granules India
ROCE (%) arrow
32.42 6.79 1.24 29.22 15.74
ROE (%) arrow
25.18 8.38 -3.85 29.77 14.34
ROA (%) arrow
21.93 4.94 -2.21 24.77 9.48
EBIT Margin (%) arrow
34.54 15.32 1.66 20.63 17.23
Net Margin (%) arrow
26.01 11.23 -3.93 14.79 11.75
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Acutaas Chemicals Wockhardt Piramal Pharma Rubicon Research Granules India
Revenue Growth (%) arrow
40.90 18.37 0.78 46.65 24.83
EBIT Growth (%) arrow
124.50 252.26 -70.53 62.13 40.39
Net Profit Growth (%) arrow
104.15 377.85 -1,383.43 89.49 38.13
EPS Growth (%) arrow
42.32 1,001.33 -484.84 78.60 34.88
Book Value Growth (%) arrow
26.03 13.47 0.33 144.31 27.49

Valuation Ratios

 Acutaas Chemicals Wockhardt Piramal Pharma Rubicon Research Granules India
Price / Earnings arrow
70.01 89.63 -89.26 91.28 32.77
Price / Book Value arrow
15.67 7.09 3.49 19.90 4.83
Dividend Yield (%) arrow
0.08 0.00 0.00 0.09 0.20
EV/EBITDA arrow
49.47 48.16 31.75 59.15 18.83
Market Cap (₹ Cr) arrow
20,944.75 19,071.62 18,108.89 12,753.19 15,391.88

Solvency Ratios

 Acutaas Chemicals Wockhardt Piramal Pharma Rubicon Research Granules India
Debt to Equity arrow
0.02 0.31 0.53 0.11 0.06
Short term debt to equity ratio arrow
0.02 0.09 0.09 0.05 0.20
Current Ratio arrow
3.82 1.61 1.51 2.01 1.80
Quick Ratio arrow
2.82 1.06 0.87 1.14 1.00
Interest Coverage arrow
141.16 3.13 0.53 10.09 8.89

Operating Efficiency Ratios

 Acutaas Chemicals Wockhardt Piramal Pharma Rubicon Research Granules India
Debtors to sales (%) arrow
24.80 16.50 23.44 26.28 16.15
Asset Turnover arrow
0.83 0.43 0.55 1.66 0.81
Receivable days arrow
88.98 58.75 78.20 40.13 33.72
Inventory Days arrow
56.04 75.82 93.30 60.29 54.92
Payable days arrow
99.95 186.21 226.14 232.47 136.11
Cash Conversion Cycle arrow
45.07 -51.64 -54.64 -132.04 -47.47
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...